These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1660340)

  • 1. Analysis of the p53 gene in human uterine carcinoma cell lines.
    Yaginuma Y; Westphal H
    Cancer Res; 1991 Dec; 51(24):6506-9. PubMed ID: 1660340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of p53 gene in gynecologic tumors].
    Yaginuma Y; Yamashita T; Duenas JC; Katayama H; Ishikawa M
    Rinsho Byori; 1994 Mar; 42(3):235-41. PubMed ID: 8152158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
    Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
    Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
    Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53.
    Liang XH; Mungal S; Ayscue A; Meissner JD; Wodnicki P; Hockenbery D; Lockett S; Herman B
    J Cell Biochem; 1995 Mar; 57(3):509-21. PubMed ID: 7768985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
    Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
    Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V
    Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of p53 gene mutations in primary nasopharyngeal carcinomas.
    Spruck CH; Tsai YC; Huang DP; Yang AS; Rideout WM; Gonzalez-Zulueta M; Choi P; Lo KW; Yu MC; Jones PA
    Cancer Res; 1992 Sep; 52(17):4787-90. PubMed ID: 1511442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 point mutation in HPV negative human cervical carcinoma cell lines.
    Crook T; Wrede D; Vousden KH
    Oncogene; 1991 May; 6(5):873-5. PubMed ID: 1646990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells.
    Storey A; Banks L
    Oncogene; 1993 Apr; 8(4):919-24. PubMed ID: 8384359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
    Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
    Yaginuma Y; Westphal H
    Cancer Res; 1992 Aug; 52(15):4196-9. PubMed ID: 1638534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.
    Murakami Y; Hayashi K; Sekiya T
    Cancer Res; 1991 Jul; 51(13):3356-61. PubMed ID: 2054775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.